[1]陈 楹,武音帆,冉 薇,等.口服营养补充对感染奥密克戎变异株的 COVID-19 老年住院病人死亡风险的影响[J].肠外与肠内营养杂志,2023,(04):198-201211.[doi:DOI : 10.16151/j.1007-810x.2023.04.002]
 CHEN Ying,WU Yin-fan,RAN Wei,et al.The effect of oral nutritional supplements on in-hospital mortality inelderly COVID-19 patients with Omicron variant infection[J].PARENTERAL & ENTERAL NUTRITION,2023,(04):198-201211.[doi:DOI : 10.16151/j.1007-810x.2023.04.002]
点击复制

口服营养补充对感染奥密克戎变异株的 COVID-19 老年住院病人死亡风险的影响()
分享到:

《肠外与肠内营养》杂志[ISSN:1007-810X/CN:32-1477/R]

卷:
期数:
2023年04期
页码:
198-201211
栏目:
论著
出版日期:
2023-08-10

文章信息/Info

Title:
The effect of oral nutritional supplements on in-hospital mortality inelderly COVID-19 patients with Omicron variant infection
作者:
陈 楹1武音帆1冉 薇1袁静珏1谈甜甜2王 莹1
1. 同济大学附属上海市第四人民医院临床营养科,上海 200434;2. 上海城建职业学院,上海201415
Author(s):
CHEN Ying1 WU Yin-fan1 RAN Wei1 YUAN Jing-jue1 TAN Tian-tian2 WANG Ying1
1. Department of Clinical Nutrition, Shanghai Fourth People’s Hospital, School of Medicine, TongjiUniversity, Shanghai 200434, China;2. Shanghai urban construction vocational college, Shanghai201415, China
关键词:
巢式病例对照 口服营养补充 老年病人 奥密克戎变异株 住院期间死亡风险
Keywords:
Nested case-control study Oral nutritional supplements Elderly patients Omicron variant Risk ofin-hospital death
分类号:
R459.3,R592
DOI:
DOI : 10.16151/j.1007-810x.2023.04.002
文献标志码:
A
摘要:
目的:探讨口服营养补充(ONS)对感染奥密克戎的老年住院病人死亡风险是否具有降低作用。 方法:回顾性收集 2022 年 4 月 11 日至 6 月 17 日同济大学附属上海市第四人民医院收治入院的奥密克戎感染老年住院病人临床资料,采用巢式病例对照研究方法,选择符合纳入和排除标准的住院期间死亡病人作为死亡组,使用倾向性匹配分析(PSM)方法为死亡组 1:10 匹配对照组。运用单因素和多因素 Logistic 回归分析服用 ONS 和住院期间死亡风险的关系。 结果:本研究纳入死亡组 25 例,对照组 147 例,平均年龄为 86(75, 91)岁。单因素 Logistic 回归结果显示,服用 ONS 相较于未服用 ONS 对感染奥密克戎的老年住院病人死亡风险具有保护作用(OR = 0.29;95%CI:0.12, 0.70; P = 0.006);多因素 Logistic 回归结果显示,调整混杂后,无论是入院早期(OR = 0.07, 95%CI: 0.01, 0.40,P = 0.003) 或者晚期服用 ONS(OR = 0.09; 95%CI: 0.02, 0.46; P = 0.004),均可以显著降低新冠老年病人住院期间死亡率。 结论:对于奥密克戎感染的老年住院病人,入院后在常规饮食的基础上增加口服营养补充,可以显著降低住院期间死亡风险。
Abstract:
Objective: We aimed to investigate whether initiating oral nutritional supplements (ONS) duringhospitalization was associated with reduced in-hospital mortality in elderly COVID-19 patients with Omicron variantinfection. Methods: Data from confirmed COVID-19 patients from April 11 to June 17 in 2022 admitted to ShanghaiFourth People’s Hospital, one of the designated medical centers for COVID-19 in Shanghai, China were collected. Thecases of in-hospital death and controls were selected after 1:10 propensity score matching (PSM) in the Nest case-controlanalysis. The univariate and multivariate logistic regression models were used to explore the association between ONSand risk of in-hospital death. Results: A total of 25 death cases and 147 controls were selected after PSM. The meanage of included patients was 86 years old (75, 91). The univariate analysis showed that ONS may be a protective factoragainst in-hospital mortality (OR = 0.29;95%CI: 0.12, 0.70; P = 0.006). The multivariate analysis showed that both earlyONS (OR = 0.07, 95%CI: 0.01, 0.40, P = 0.003) and delayed ONS (OR = 0.09; 95%CI: 0.02, 0.46; P = 0.004) couldsignificantly lower risks of in-hospital death in elderly COVID-19 patients. Conclusion: Initiating ONS duringhospitalization could significantly lower risk of in-hospital death in elderly patients with Omicron variant infection.

参考文献/References:


[1] Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun,2020, 109: 102433.
[2] Feng C, Hong S, Fan R, et al. Age and Sex Differences Among Mildly Symptomatic and Asymptomatic Patients with Omicron Infection in 2022 in Shanghai, China. J Multidiscip Healthc,2022, 15: 1909-1919.
[3] 吴 俣, 刘 珏, 刘 民, 等 . 新型冠状病毒 Omicron 变异株的流行病学特征及其科学防控建议 . 中华疾病控制杂志, 2022, 26(5): 497-501.
[4] 陈 兵, 刘效辉, 赵 林, 等 . 2022 年上海市某方舱医院收治的3054 例新冠轻型/无症状感染病例的流行病学特征 . 中华医院感染学杂志,2022,32(24):3681-3686.
[5] Wong C, Au I, Lau K, et al. Real-world effectiveness ofmolnupiravir and nirmatrelvir plus ritonavir against mortality,hospitalisation, and in-hospital outcomes among communitydwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: anobservational study. Lancet, 2022, 400(10359): 1213-1222.
[6] 中华医学会肠内肠外营养学分会专家组 . 关于新型冠状病毒肺炎患者的医学营养治疗专家建议 . 中华普通外科学文献(电子版), 2020, 14(1): 1.
[7] 吴秀文 . 新型冠状病毒肺炎营养治疗的研究进展 . 肠外与肠内营养, 2020, 27(3): 133-135.
[8] 新型冠状病毒肺炎诊疗方案(试行第九版). 心肺血管病杂志,2022, 41(5): 449-457.
[9] Qi G, Wang H, Guo Y, et al. Clinical outcomes of COVID-19patients with rheumatic diseases: a retrospective cohort study andsynthesis analysis in Wuhan, China. Clin Rheumatol, 2022, 41(6):1899-1910.
[10] Meizlish ML, Goshua G, Liu Y, et al. Intermediate-doseanticoagulation, aspirin, and in-hospital mortality in COVID-19:A propensity score-matched analysis. Am J Hematol, 2021, 96(4):471-479.
[11] Hernández JL, Nan D, Fernandez-Ayala M, et al. Vitamin DStatus in Hospitalized Patients with SARS-CoV-2 Infection. JClin Endocrinol Metab, 2021, 106(3): e1343-53.
[12] 陈怡洁, 陈卓敏, 王笑华, 等 . 感染奥密克戎变异株的 2019 冠状病毒病轻型和普通型患者核酸检测转阴时间影响因素分析 . 浙江大学学报(医学版),2022,51(6):731-737.
[13] Barazzoni R, Bischoff SC, Breda J, et al. ESPEN expertstatements and practical guidance for nutritional management ofindividuals with SARS-CoV-2 infection. Clin Nutr, 2020, 39(6):1631-1638.
[14] Zhang P, He Z, Yu G, et al. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosisprediction in critically ill COVID-19 patients. Clin Nutr, 2021, 40(2): 534-541.
[15] 张家瑛, 邵春海, 杨嘉红, 等 . 新型冠状病毒肺炎危重症患者营养治疗专家建议 . 中国临床医学, 2020, 27(2): 167-174.
[16] Mentella MC, Scaldaferri F, Gasbarrini A, et al. The Role ofNutrition in the COVID-19 Pandemic. Nutrients, 2021, 13(4):1093.
[17] Li T, Zhang Y, Gong C, et al. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 inWuhan, China. Eur J Clin Nutr, 2020, 74(6): 871-875.
[18] Di Filippo L, De Lorenzo R, D’Amico M, et al. COVID-19 isassociated with clinically significant weight loss and risk ofmalnutrition, independent of hospitalisation: A post-hoc analysisof a prospective cohort study. Clin Nutr, 2021, 40(4): 2420-2426.
[19] 陈 伟 .《新型冠状病毒感染的肺炎防治营养膳食指导》临床应用解读 . 北京医学, 2020, 42(3): 181-182.
[20] Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr, 2019, 38(1): 10-47.
[21] Iddir M, Brito A, Dingeo G, et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stressthrough Diet and Nutrition: Considerations during the COVID-19Crisis. Nutrients, 2020, 12(6):1562.
[22] 肖刘牛, 冉 晓, 钟燕霞, 等 . 早期肠内营养在重症新冠肺炎病人炎症因子及临床预后中的研究 . 肠外与肠内营养, 2021, 28(2): 65-71.
[23] Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet, 2019, 393(10188): 2312-2321.

相似文献/References:

[1]乔 惠,陈佩娟,王 丽,等.医护药养一体化模式对鼻咽癌病人口服营养补充依从性及生活质量的影响[J].肠外与肠内营养杂志,2018,(06):337.[doi:10.16151/j.1007-810x.2018.11.004]
 QIAO Hui,CHEN Pei-juan,WANG Li,et al.Influence of ONS compliance and quality of life ofmulti-disciplinary mode on the patients with nasopharyngeal carcinoma[J].PARENTERAL & ENTERAL NUTRITION,2018,(04):337.[doi:10.16151/j.1007-810x.2018.11.004]
[2]邓桂芳,等.术前口服营养补充对消化道恶性肿瘤病人营养状况及临床结局的影响[J].肠外与肠内营养杂志,2019,(04):208.[doi:DOI : 10.16151/j.1007-810x.2019.04.004]
 DENG Gui-fang,LI Cui-yu,WEI Yuan-huan,et al.Effect of preoperative oral nutritional supplement on nutritional status and clinical outcome for patients with digestive tract malignancies[J].PARENTERAL & ENTERAL NUTRITION,2019,(04):208.[doi:DOI : 10.16151/j.1007-810x.2019.04.004]
[3]常 颖,范锐心,章露文,等.术后口服营养补充和规范化饮食干预对剖宫产 产妇早期恢复情况的效果研究[J].肠外与肠内营养杂志,2020,(03):162.[doi:DOI : 10.16151/j.1007-810x.2020.03.008 ]
 CHANG Ying,FAN Rui-xin,ZHANG Lu-wen,et al.Effects of oral nutrition supplements and standard dietary intervention on postpartum recovery in parturients with cesarean section[J].PARENTERAL & ENTERAL NUTRITION,2020,(04):162.[doi:DOI : 10.16151/j.1007-810x.2020.03.008 ]
[4]刘 莹,李 婷,侯海燕,等.营养专科护士主导的目标执行管理模式对胃肠道肿瘤病人围术期口服营养补充依从性的效果研究[J].肠外与肠内营养杂志,2023,(03):160.[doi:10.16151/j.1007-810x.2023.03.007]
 LIU Ying,LI Ting,HOU Hai-yan,et al.The effect of nutrition specialist nurse-led target execution management mode on perioperative oral nutritional supplement compliance in patients with gastrointestinal tumors[J].PARENTERAL & ENTERAL NUTRITION,2023,(04):160.[doi:10.16151/j.1007-810x.2023.03.007]

备注/Memo

备注/Memo:
基金项目 :上海市虹口区科学技术委员会医学课题(2102-08)作者简介 :陈 楹,住院医师,医学硕士,主要研究营养与慢性病。E-mail: chenyemma@163.com通讯作者 :王 莹,E-mail: 18916484569@163.com
更新日期/Last Update: 1900-01-01